title: High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
abstract: Neutralizing antibodies (NA) against HIV-1MN and HIV-1IIIB, and antibodies binding to synthetic peptides (BA) derived from the gp120 envelope V3 region principal neutralizing determinants (PND) of the HIV-1MN, HIV-1IIIB, and HIV-1Z3 virus strains were assayed in HIV-1 antibody-positive sera from the United States, Haiti, Brazil, Zaire, and Zimbabwe. The ability of soluble PND peptide to block neutralization of the corresponding virus by representative sera was also tested. In each country, NA and BA titers were highest against the HIV-1MN strain, and compared with other countries, NA and BA titers against HIV-1MN were higher in sera from the United States and Haiti. When NA titers were compared with BA titers against either HIV-1MN or HIV-1IIIB, no correlation was found for the HIV-1IIIB strain, but there was a significant correlation for HIV-1MN. Addition of the HIV-1MN strain peptide to a neutralization assay for HIV-1MN resulted in a four- to tenfold reduction in NA titers in sera from the United States, Zaire, and Brazil. The results suggest that HIV-1MN and closely related variants are prevalent in many parts of the world, and that antibodies directed against the PND account for most of the neutralizing activity in sera of infected individuals.
authors.affiliation: Division of Virology, Food and Drug Administration, Bethesda, MD.
authors.forename: E W
authors.initials: EW
authors.lastname: Carrow
authors.forename: L K
authors.initials: LK
authors.lastname: Vujcic
authors.forename: W L
authors.initials: WL
authors.lastname: Glass
authors.forename: K B
authors.initials: KB
authors.lastname: Seamon
authors.forename: S C
authors.initials: SC
authors.lastname: Rastogi
authors.forename: R M
authors.initials: RM
authors.lastname: Hendry
authors.forename: R
authors.initials: R
authors.lastname: Boulos
authors.forename: N
authors.initials: N
authors.lastname: Nzila
authors.forename: G V
authors.initials: GV
authors.lastname: Quinnan
mesh_terms: D000349:Africa; D000569:Americas; D000595:Amino Acid Sequence; D001667:Binding, Competitive; D000939:Epitopes; D015483:HIV Antibodies / Q000097:blood*; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry / Q000276:immunology
chemical_list: D000939:Epitopes; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D010455:Peptides